Brief: Ziyad Binsalamah Reports 7.43% Stake In Interpace Diagnostics Group As Of July 21
July 24 (Reuters) - Interpace Biosciences Inc IDXG.O :
* ZIYAD BINSALAMAH REPORTS 7.43% STAKE IN INTERPACE
DIAGNOSTICS
GROUP AS OF JULY 21 - SEC FILING
Source text: [ID:https://bit.ly/3hyIUW9]
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million